1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]-

Request For Quotation
1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]- Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: Shanghai Amole Biotechnology Co., Ltd.  
Tel: 13370042665 18916960931
Email: 2596183085@qq.com

1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]- manufacturers

  • EPZ032597
  • EPZ032597 pictures
  • $350.00
  • 2026-07-14
  • CAS:1887193-58-9
  • Purity: 99.97%
  • Supply Ability: 10g
1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]- Basic information
Product Name:1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]-
Synonyms:1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]-;EPZ032597
CAS:1887193-58-9
MF:C20H23N7O
MW:377.44
EINECS:
Product Categories:
Mol File:1887193-58-9.mol
1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]- Structure
1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]- Chemical Properties
density 1.44±0.1 g/cm3(Predicted)
pka12.93±0.20(Predicted)
Safety Information
MSDS Information
1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]- Usage And Synthesis
UsesEPZ032597 is a selective and noncompetitive SMYD2 inhibitor with an IC50 value of 16 nM. EPZ032597 is promising for research of pancreatic ductal adenocarcinoma[1][2].
References[1] Alshammari E, et al. Mechanistic and functional extrapolation of SET and MYND domain-containing protein 2 to pancreatic cancer. World J Gastroenterol. 2022 Aug 7;28(29):3753-3766. DOI:10.3748/wjg.v28.i29.3753
[2] Thomenius MJ, et al. Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation. PLoS One. 2018 Jun 1;13(6):e0197372. DOI:10.1371/journal.pone.0197372
1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]- Preparation Products And Raw materials
Tag:1H-1,2,3-Triazole-4-carboxamide, 1-cyclopropyl-N-[1-[[1-(phenylmethyl)-1H-pyrazol-4-yl]methyl]-3-azetidinyl]-(1887193-58-9) Related Product Information
UNC 1999 EPZ015666 GSK-3326595 UNC-0642 UNC0638 DS-3201